Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Taylor ML et al. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects. 1996 Clin. Exp. Allergy pmid:8835129
Barkai U and Kraicer PF Intrauterine signaling and embryonic implantation. 1996 Mar-Apr Biol. Signals pmid:8836494
Louis RE and Radermecker MF Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. 1996 Eur. Respir. J. pmid:8836652
Kurata M et al. A comparative study of whole-blood platelet aggregation in laboratory animals: its species differences and comparison with turbidimetric method. 1995 Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol. pmid:8838690
Imagawa M et al. Modulation of platelet-activating factor synthesis by recombinant interferon-alpha in human renal cell carcinoma. 1996 Urol. Int. pmid:8840484
Isogai E et al. [Platelet activating factor (PAF) and Lyme disease]. 1996 Nippon Saikingaku Zasshi pmid:8840817
Tenor H et al. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. 1996 Br. J. Pharmacol. pmid:8842438
Paulino N et al. Mechanisms involved in the contractile responses induced by the hydroalcoholic extract of Phyllanthus urinaria on the guinea pig isolated trachea: evidence for participation of tachykinins and influx of extracellular Ca2+ sensitive to ruthenium red. 1996 Gen. Pharmacol. pmid:8842681
Kemény L et al. Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice. 1996 Arch. Dermatol. Res. pmid:8844132
Libert C et al. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality. 1995-1996 J. Inflamm. pmid:8844494
Yokota K et al. Inhibitory effects of the new anti-platelet agent KBT-3022 and its metabolite on rabbit neutrophil function in vitro. 1996 Jpn. J. Pharmacol. pmid:8847836
Hahn M et al. Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation. 1995 Cardiovasc Drugs Ther pmid:8850387
Renesto P et al. Protective effect of platelet activating factor antagonists on cultured endothelial cell lysis induced by elastase or activated neutrophils. 1996 Br. J. Pharmacol. pmid:8851508
Hoffman BF et al. Arrhythmias caused by platelet activating factor. 1996 J. Cardiovasc. Electrophysiol. pmid:8853022
Gaylord MS et al. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. 1996 Am. J. Med. Sci. pmid:8853062
Ebara T et al. Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock. 1996 Jpn. J. Pharmacol. pmid:8854207
Chen CC et al. Tumor necrosis factor-alpha, platelet-activating factor, and hydrogen peroxide activate protein kinase C subtypes alpha and epsilon in human saphenous vein endothelial cells. 1996 J. Cardiovasc. Pharmacol. pmid:8856479
Albert DH et al. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats. 1996 Shock pmid:8856845
Mastroroberto P et al. Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis. 1996 Scand J Thorac Cardiovasc Surg pmid:8857679
Abu-Zidan FM et al. Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs. 1996 J Trauma pmid:8858021
Lopes-Martins R et al. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure. 1996 Eur. J. Pharmacol. pmid:8858301
Shi LC et al. Guanine nucleotide regulatory proteins, Gq and Gi1/2, mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells. 1996 J. Neurochem. pmid:8858930
Jouët P and Sarna SK Platelet-activating factor (PAF) stimulates giant migrating contractions during ileal inflammation. 1996 J. Pharmacol. Exp. Ther. pmid:8858995
Saito H et al. Histamine augments VCAM-1 expression on IL-4- and TNF-alpha-stimulated human umbilical vein endothelial cells. 1996 Int. Arch. Allergy Immunol. pmid:8859220
Wang X et al. Potentiation of acetylcholine-induced responses in freshly isolated rabbit aortic endothelial cells. 1996 Sep-Oct J. Vasc. Res. pmid:8862147
Denizot Y et al. PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells. 1996 Exp. Hematol. pmid:8862444
Kingsnorth AN Platelet-activating factor. 1996 Scand. J. Gastroenterol. Suppl. pmid:8865468
Medina JH and Izquierdo I Retrograde messengers, long-term potentiation and memory. 1995 Brain Res. Brain Res. Rev. pmid:8866674
Kamata K et al. Characteristics of vasodilatation induced by acetylcholine and platelet-activating factor in the rat mesenteric arterial bed. 1996 Eur. J. Pharmacol. pmid:8867099
Ackerman Z et al. Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension. 1996 Liver pmid:8868072
Guastoni C et al. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes. 1996 Clin. Nephrol. pmid:8869791
Elferink JG and de Koster BM Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c. 1996 Chem. Biol. Interact. pmid:8870686
Huang YH et al. Induction of IL-4 by platelet-activating factor. 1996 Clin. Exp. Immunol. pmid:8870712
Weller PF et al. Role of the eosinophil in allergic reactions. 1996 Eur Respir J Suppl pmid:8871054
Kecskeméti V and Balogh I Cardiac ultrastructural effects of the platelet-activating factor and its antagonist BN 52021. 1995 Exp. Toxicol. Pathol. pmid:8871085
Baluk P et al. NK1 receptor antagonist CP-99,994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules. 1996 Jul-Aug Exp. Lung Res. pmid:8872085
Poch B et al. Release of histamine in whole blood by oxygen radicals: division between specific and unspecific processes. 1996 Inflamm. Res. pmid:8872518
Balsa D et al. Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard method. 1996 J Pharmacol Toxicol Methods pmid:8872920
Tenscher K et al. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. 1996 Blood pmid:8874220
Takafuji S et al. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. 1996 Allergy pmid:8874660
Verhoef J et al. Issues in the adjunct therapy of severe sepsis. 1996 J. Antimicrob. Chemother. pmid:8877531
Zimmerman GA et al. Adhesion and signaling in vascular cell--cell interactions. 1996 J. Clin. Invest. pmid:8878418
Fukao M et al. Structural differences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric arteries. 1996 Biochem. Biophys. Res. Commun. pmid:8878540
Fairbairn SM et al. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease. 1996 Res. Vet. Sci. pmid:8880978
Perretti M et al. Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1. 1996 Br. J. Pharmacol. pmid:8882609
Siegel A and Baker RR Activities of enzymes in platelet activating factor biosynthetic pathways in the gerbil model of cerebral ischemia. 1996 Biochem. Cell Biol. pmid:8883840
Ferreira HH et al. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis. 1996 Eur. J. Pharmacol. pmid:8884218
Enzan K et al. Thromboxane rather than platelet activating factor mediates pulmonary vasoconstriction after antigen challenge in rabbits. 1996 Shock pmid:8885083
Niu XF et al. A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. 1996 Circ. Res. pmid:8888691
Nishida K and Markey SP Nicardipine and MK-801 attenuate platelet-activating factor increases following cerebral ischemia-reperfusion in gerbils. 1996 Brain Res. pmid:8891303
Alves AC et al. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. 1996 Eur. J. Pharmacol. pmid:8891583
Krüll M et al. Escherichia coli hemolysin and Staphylococcus aureas alpha-toxin potently induce neutrophil adhesion to cultured human endothelial cells. 1996 J. Immunol. pmid:8892649
Mancuso F et al. Inhibition of zymosan-induced air-pouch inflammation by rat seminal vesicle protein and by its spermidine derivative. 1996 Eur. J. Pharmacol. pmid:8894615
Ishizuka T et al. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells. 1996 Eur. J. Pharmacol. pmid:8894620
Winlove CP et al. Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties. 1996 Diabetologia pmid:8896999
Lithner F Diabetes mellitus and Alzheimer's disease. 1996 Diabetologia pmid:8897018
Cominacini L et al. Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL. 1996 Diabetologia pmid:8897020
Catalán RE et al. Endothelin stimulates phosphoinositide hydrolysis and PAF synthesis in brain microvessels. 1996 J. Cereb. Blood Flow Metab. pmid:8898708
Kishi K et al. Gq-coupled receptors transmit the signal for GLUT4 translocation via an insulin-independent pathway. 1996 J. Biol. Chem. pmid:8900127
Cortijo J et al. Antiasthma activity of the novel antihistamine E-4716 in guinea pigs in vivo. 1996 Methods Find Exp Clin Pharmacol pmid:8900220
Fujimura M et al. Involvement of PAF in postallergic propranolol-induced bronchoconstriction in guinea-pigs. 1996 Eur. Respir. J. pmid:8902468
Koyama M et al. Surface coverage of vascular grafts with cultured human endothelial cells from subcutaneous fat tissue obtained with a biopsy needle. 1996 Thromb. Haemost. pmid:8903004
Greenberg SS et al. Ethanol suppresses endotoxin but not platelet activating factor-induced hypotension and nitric oxide. 1996 Alcohol. Clin. Exp. Res. pmid:8904980
Kishimoto S et al. Enhanced expression of platelet-activating factor receptor on human eosinophils by interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor. 1996 Int. Arch. Allergy Immunol. pmid:8906117
Neville LF et al. Application of differential display to isolate novel genes in interleukin-2-induced adult respiratory distress syndrome. 1996 Ann. N. Y. Acad. Sci. pmid:8906233
Francescangeli E et al. Relative contribution of the de novo and remodelling pathways to the synthesis of platelet-activating factor in brain areas and during ischemia. 1996 J Lipid Mediat Cell Signal pmid:8906550
Hattori M et al. PAF and PAF acetylhydrolase in the nervous system. 1996 J Lipid Mediat Cell Signal pmid:8906551
Shimizu T et al. Platelet-activating factor and somatostatin activate mitogen-activated protein kinase (MAP kinase) and arachidonate release. 1996 J Lipid Mediat Cell Signal pmid:8906552
Feuerstein GZ Platelet-activating factor: a case for its role in CNS function and brain injury. 1996 J Lipid Mediat Cell Signal pmid:8906553
Kornecki E et al. Platelet activating factor (PAF) in memory formation: role as a retrograde messenger in long-term potentiation. 1996 J Lipid Mediat Cell Signal pmid:8906554
Bazan NG and Allan G Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression. 1996 J Lipid Mediat Cell Signal pmid:8906578
Williams JH Retrograde messengers and long-term potentiation: a progress report. 1996 J Lipid Mediat Cell Signal pmid:8906579
Kato K and Zorumski CF Platelet-activating factor as a potential retrograde messenger. 1996 J Lipid Mediat Cell Signal pmid:8906580
Thivierge M et al. Modulation of human platelet-activating factor receptor gene expression by protein kinase C activation. 1996 J. Immunol. pmid:8906849
Kleuser B et al. Measurement of phospholipase A2 and 1-alkylglycerophosphocholine acetyltransferase activities in stimulated alveolar macrophages by HPLC analysis of NBD-labeled ether lipids. 1996 Chem. Phys. Lipids pmid:8907240
Herbert JM et al. Hypoxia primes endotoxin-induced tissue factor expression in human monocytes and endothelial cells by a PAF-dependent mechanism. 1996 J. Cell. Physiol. pmid:8908196
Richardson RM et al. Cross-desensitization among receptors for platelet activating factor and peptide chemoattractants. Evidence for independent regulatory pathways. 1996 J. Biol. Chem. pmid:8910508
Martínez-Cuesta MA et al. Involvement of prostaglandins and 5-hydroxytryptamine in the contractile effect of platelet-activating factor in rat isolated gastric corpus. 1996 J. Pharm. Pharmacol. pmid:8910861
Condliffe AM et al. Priming differentially regulates neutrophil adhesion molecule expression/function. 1996 Immunology pmid:8911147
Walsh GM et al. Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. 1996 Immunology pmid:8911148
Elizarova EP Effects of taurine on calcium in platelets and their aggregation. 1996 Adv. Exp. Med. Biol. pmid:8915398
Kimura S et al. Heterogeneity of drug susceptibility of mouse active anaphylactic shock. 1996 Sep-Nov Immunol. Invest. pmid:8915680
Lin J et al. Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitro. 1996 Ann. Otol. Rhinol. Laryngol. pmid:8916869
Liu CY and Kuo HP The different effect of salbutamol and aminophylline on platelet activating factor-induced plasma exudation into guinea pig tracheal wall and lumen. 1996 Changgeng Yi Xue Za Zhi pmid:8921637
Wang KS and Monden M Ex vivo evidence of platelet activating factor on ischemic liver injury. 1996 Changgeng Yi Xue Za Zhi pmid:8921640
da Silva MB et al. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine. 1996 Zentralbl Veterinarmed A pmid:8921726
Kurosawa M et al. CV6209 inhibits airway wall thickening and airway hyperresponsiveness to histamine induced by intravenous administration of platelet-activating factor in guinea pigs. 1996 J Lipid Mediat Cell Signal pmid:8925195
Nowak D et al. Comparison of PAF- and fMLP-induced [Ca2+]i transients in human polymorphonuclear leukocytes. 1996 J Lipid Mediat Cell Signal pmid:8925197
Montrucchio G et al. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin. 1996 Circulation pmid:8925584
Walker BA Effects of adenosine on guinea pig pulmonary eosinophils. 1996 Inflammation pmid:8926045
Staffolani N et al. [The measurement of PAF (platelet activating factor) in human saliva: standardization of the method]. 1996 Minerva Stomatol pmid:8926976
Brus F et al. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. 1996 Pediatr. Res. pmid:8929866
Cardile V et al. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro. 1996 Cytokine pmid:8932980
el-Shazly AE et al. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate. 1996 Immunopharmacol Immunotoxicol pmid:8933171
Qu X et al. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. 1996 Prostaglandins pmid:8935185
Muraki T et al. Effect of S-ethylisothiourea, a putative inhibitor of inducible nitric oxide synthase, on mouse skin vascular permeability. 1996 Jpn. J. Pharmacol. pmid:8935721
Klosterhalfen B et al. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. 1996 Biochem. Pharmacol. pmid:8937427
Uhlig S et al. Effect of urodilatin on platelet-activating factor-induced bronchoconstriction, vasoconstriction and edema formation in isolated rat lung. 1996 Naunyn Schmiedebergs Arch. Pharmacol. pmid:8938670
Tocher DR et al. Production of eicosanoids derived from 20:4n-6 and 20:5n-3 in primary cultures of turbot (Scophthalmus maximus) brain astrocytes in response to platelet activating factor, substance P and interleukin-1 beta. 1996 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:8939002
Darbha S and Marchase RB Regulation of intracellular calcium is closely linked to glucose metabolism in J774 macrophages. 1996 Cell Calcium pmid:8939356